{"nct_id":"NCT01568866","title":"Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients","status":"COMPLETED","status_verified_date":"2022-11","start_date":"2012-06-20","start_date_type":"ACTUAL","primary_completion_date":"2014-11-10","primary_completion_date_type":"ACTUAL","completion_date":"2018-02-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}